Literature DB >> 3139895

Protective factors in posterior urethral valves.

M H Rittenberg1, W C Hulbert, H M Snyder, J W Duckett.   

Abstract

Patients with posterior urethral valves may present with or contract renal insufficiency. High intravesical pressure that is transmitted to the upper urinary tract in utero is a likely contributing cause. We have identified 3 anatomical associations with posterior urethral valves that provide a pressure "pop-off" mechanism resulting in preservation of better renal function: 1) the syndrome of posterior urethral valves, unilateral vesicoureteral reflux and renal dysplasia; 2) large congenital type bladder diverticula and 3) urinary extravasation with or without urinary ascites. Followup of 71 boys with posterior urethral valves was sufficient to permit long-term analysis. Serum creatinine was used as an index of renal function and prognosis. Of the 71 boys 20 (28 per cent) had 1 of the 3 protective mechanisms. Only 1 child (5 per cent) had a serum creatinine greater than 1.0 mg. per cent. Of the remaining 51 boys without a "pop-off" mechanism 20 (39 per cent) had serum creatinine greater than 1.0 mg. per cent and 7 had already progressed to renal dialysis and/or transplantation. The difference in serum creatinine was statistically significant (p less than 0.01). Thus, the syndrome of posterior urethral valves, unilateral vesicoureteral reflux and renal dysplasia; large congenital bladder diverticula and urinary extravasation can serve as a "pop-off" mechanism to buffer high pressures in the urinary tract and to lead to the preservation of better renal function in boys with posterior urethral valves.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139895     DOI: 10.1016/s0022-5347(17)41908-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

Review 1.  Postnatal management of hydronephrosis diagnosed in utero.

Authors:  J Radhakrishnan; G Lievano
Journal:  Indian J Pediatr       Date:  1997 May-Jun       Impact factor: 1.967

2.  Risk factors for renal insufficiency in children with urethral valves.

Authors:  Michael Pohl; Hans-Joachim Mentzel; Susanna Vogt; Mario Walther; Gabriele Rönnefarth; Ulrike John
Journal:  Pediatr Nephrol       Date:  2011-10-19       Impact factor: 3.714

Review 3.  Tumour in a giant bladder diverticulum: a case report and review of literature.

Authors:  B Shah; R Rodriguez; S Krasnokutsky; S M Shah; S Ali Khan
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

4.  Congenital posterior urethral obstruction: the historical perspective.

Authors:  P A Dewan
Journal:  Pediatr Surg Int       Date:  1997-02       Impact factor: 1.827

5.  Evolution of upper urinary tract and renal function in patients with posterior urethral valves.

Authors:  G Belloli; F Battaglino; A Mercurella; L Musi; D D'Agostino
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

6.  Urinoma formation in posterior urethral valves: relationship to later renal function.

Authors:  S K Fernbach; K A Feinstein; M R Zaontz
Journal:  Pediatr Radiol       Date:  1990

7.  Neonatal urinary ascites due to unilateral vesicoureteric junction obstruction.

Authors:  K E Chun; R S Ferguson
Journal:  Pediatr Surg Int       Date:  1997-07       Impact factor: 1.827

Review 8.  Acute perirenal extravasation of urine in an infant with non-refluxing megaureter.

Authors:  Rolf Beetz; Raimund Stein; Petra Rohatsch; Rita Brzezinska; Jochen W Thüroff
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

9.  Fetal urinoma and prenatal hydronephrosis: how is renal function affected?

Authors:  Tayfun Oktar; Emre Salabaş; İbrahim Kalelioğlu; Arda Atar; Haluk Ander; Orhan Ziylan; Recep Has; Atıl Yüksel
Journal:  Turk J Urol       Date:  2013-06

10.  Prognostic factors of posterior urethral valves and the role of antenatal detection.

Authors:  Elisa Ylinen; Marja Ala-Houhala; Sakari Wikström
Journal:  Pediatr Nephrol       Date:  2004-06-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.